Elekta has announced that Gustaf Salford has been appointed to the role of President and CEO, effective immediately. He has been Acting CEO since early June 2020.
Elekta’s Board of Directors carried out an extensive search process, with the conclusion that Gustaf Salford fulfills all criteria that Elekta needs to continue to drive successful development.
Laurent Leksell, Founder and Chairman of the Board of Directors, said: “We are very pleased that Gustaf has accepted this position. Gustaf started at Elekta eleven years ago and has successfully assumed various roles, always impressing us on the Board as a proven leader with deep competence and international business acumen. Gustaf’s most recent role within Elekta has been as our CFO. Gustaf Salford will continue to be a very trusted leader by the company, as well as a very strong ally to our customers worldwide.”
In addition to an MSc degree in Business Administration from the Stockholm School of Economics, Salford brings broad experience from different roles at Elekta and previously from senior management consulting, as well as intimate knowledge of the medical device industry.
“I am honored to take on the role of President and CEO of this fantastic company. And I will, together with my team, accelerate Elekta’s strategy and future profitable growth. As the leader in precision radiation medicine we strive to increase accessibility to cancer care, build resilience and continue to push and expand the boundaries for innovation,” said Gustaf Salford.Back To Top
Elekta Names Gustaf Salford as President, CEO. Appl Rad Oncol.